TI
CRBU icon

Trexquant Investment’s Caribou Biosciences CRBU Stock Holding History

Trexquant Investment’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-11,152
Closed -$63.9K – 1478
2023
Q4 		$63.9K Sell
11,152
-202,992
-95% -$1M ﹤0.01% 1370
2023
Q3 		$1.02M Buy
214,144
+125,277
+141% +$777K 0.03% 740
2023
Q2 		$378K Buy
+88,867
New +$399K 0.01% 1111
2022
Q2 		– Sell
-13,981
Closed -$128K – 1567
2022
Q1 		$128K Buy
+13,981
New +$147K 0.01% 1261

Other funds holding CRBU

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
EWM
Elmwood Wealth Management Berkeley, California $400M AUM 17.81% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Trexquant Investment's CRBU Position: Q1 2024 in Review

Trexquant Investment sold out of Caribou Biosciences (CRBU) in Q1 2024, closing a stake of 11,152 shares — an estimated $63.9K sold.

Trexquant Investment first reported a position in CRBU in Q1 2022 and held it in 4 quarters. The position peaked at $1.02M in Q3 2023. 151 funds tracked by Wall St. Rank hold CRBU as of Q1 2024.

  • Trexquant Investment reported no remaining Caribou Biosciences position as of Q1 2024 after selling out during the quarter.
  • Trexquant Investment sold 11,152 Caribou Biosciences shares in Q1 2024, an estimated $63.9K.
  • Trexquant Investment first reported a position in Caribou Biosciences in Q1 2022 and held it in 4 quarters.
  • Trexquant Investment's Caribou Biosciences position peaked at $1.02M in Q3 2023.
  • 151 funds tracked by Wall St. Rank held Caribou Biosciences as of Q1 2024.

Based on Trexquant Investment's 13F filing for Q1 2024, filed 14 May 2024.